Suppr超能文献

在一系列负链病毒中,Hsp90抑制后的抗病毒活性及RNA聚合酶降解

Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.

作者信息

Connor John H, McKenzie Margie O, Parks Griffith D, Lyles Douglas S

机构信息

Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA.

出版信息

Virology. 2007 May 25;362(1):109-19. doi: 10.1016/j.virol.2006.12.026. Epub 2007 Jan 26.

Abstract

We have analyzed the effectiveness of Hsp90 inhibitors in blocking the replication of negative-strand RNA viruses. In cells infected with the prototype negative strand virus vesicular stomatitis virus (VSV), inhibiting Hsp90 activity reduced viral replication in cells infected at both high and low multiplicities of infection. This inhibition was observed using two Hsp90 inhibitors geldanamycin and radicicol. Silencing of Hsp90 expression using siRNA also reduced viral replication. Hsp90 inhibition changed the half-life of newly synthesized L protein (the large subunit of the VSV polymerase) from >1 h to less than 20 min without affecting the stability of other VSV proteins. Both the inhibition of viral replication and the destabilization of the viral L protein were seen when either geldanamycin or radicicol was added to cells infected with paramyxoviruses SV5, HPIV-2, HPIV-3, or SV41, or to cells infected with the La Crosse bunyavirus. Based on these results, we propose that Hsp90 is a host factor that is important for the replication of many negative strand viruses.

摘要

我们分析了热休克蛋白90(Hsp90)抑制剂在阻断负链RNA病毒复制方面的有效性。在感染了原型负链病毒水疱性口炎病毒(VSV)的细胞中,抑制Hsp90活性可降低在高感染复数和低感染复数下感染细胞中的病毒复制。使用两种Hsp90抑制剂格尔德霉素和萝卜硫素观察到了这种抑制作用。使用小干扰RNA(siRNA)使Hsp90表达沉默也降低了病毒复制。Hsp90抑制作用将新合成的L蛋白(VSV聚合酶的大亚基)的半衰期从>1小时缩短至不到20分钟,而不影响其他VSV蛋白的稳定性。当将格尔德霉素或萝卜硫素添加到感染副粘病毒SV5、人副流感病毒2型(HPIV-2)、人副流感病毒3型(HPIV-3)或SV41的细胞中,或添加到感染拉克罗斯布尼亚病毒的细胞中时,均可观察到病毒复制受到抑制以及病毒L蛋白不稳定。基于这些结果,我们提出Hsp90是一种对许多负链病毒复制很重要的宿主因子。

相似文献

1
Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.
Virology. 2007 May 25;362(1):109-19. doi: 10.1016/j.virol.2006.12.026. Epub 2007 Jan 26.
2
Inhibition of heat-shock protein 90 reduces Ebola virus replication.
Antiviral Res. 2010 Aug;87(2):187-94. doi: 10.1016/j.antiviral.2010.04.015. Epub 2010 May 7.
3
Heat shock protein 90: role in enterovirus 71 entry and assembly and potential target for therapy.
PLoS One. 2013 Oct 2;8(10):e77133. doi: 10.1371/journal.pone.0077133. eCollection 2013.
5
Hsp90 inhibitors reduce influenza virus replication in cell culture.
Virology. 2008 Aug 1;377(2):431-9. doi: 10.1016/j.virol.2008.04.040.
8
Heat shock protein 90 regulates the stability of MEKK3 in HEK293 cells.
Cell Immunol. 2009;259(1):49-55. doi: 10.1016/j.cellimm.2009.05.012. Epub 2009 Jun 6.

引用本文的文献

1
Overview of host-directed antiviral targets for future research and drug development.
Acta Pharm Sin B. 2025 Apr;15(4):1723-1751. doi: 10.1016/j.apsb.2025.03.011. Epub 2025 Mar 8.
2
Functional dissection of the C-terminal domain of rabies virus RNA polymerase L protein.
J Virol. 2025 Apr 15;99(4):e0208224. doi: 10.1128/jvi.02082-24. Epub 2025 Mar 11.
8
Hsp90 Regulates GCRV-II Proliferation by Interacting with VP35 as Its Receptor and Chaperone.
J Virol. 2022 Oct 12;96(19):e0117522. doi: 10.1128/jvi.01175-22. Epub 2022 Sep 14.
9
Host cell stress response as a predictor of COVID-19 infectivity and disease progression.
Front Mol Biosci. 2022 Aug 11;9:938099. doi: 10.3389/fmolb.2022.938099. eCollection 2022.
10
Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy.
Biomedicines. 2022 Aug 19;10(8):2024. doi: 10.3390/biomedicines10082024.

本文引用的文献

1
A unique strategy for mRNA cap methylation used by vesicular stomatitis virus.
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8493-8. doi: 10.1073/pnas.0509821103. Epub 2006 May 18.
2
Identification of a new region in the vesicular stomatitis virus L polymerase protein which is essential for mRNA cap methylation.
Virology. 2006 Jul 5;350(2):394-405. doi: 10.1016/j.virol.2006.02.021. Epub 2006 Mar 13.
4
HSP90 and the chaperoning of cancer.
Nat Rev Cancer. 2005 Oct;5(10):761-72. doi: 10.1038/nrc1716.
5
Recent highlights in the development of new antiviral drugs.
Curr Opin Microbiol. 2005 Oct;8(5):552-60. doi: 10.1016/j.mib.2005.08.010.
10
Constantly updated knowledge of Hsp90.
J Biochem. 2005 Apr;137(4):443-7. doi: 10.1093/jb/mvi056.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验